372 filings
Page 4 of 19
6-K
NYMXF
Nymox Pharmaceutical Corp
14 Aug 20
Nymox Announces Closing of $9 Million Registered Direct Offering
4:07pm
6-K
NYMXF
Nymox Pharmaceutical Corp
14 Aug 20
Current report (foreign)
4:02pm
424B5
NYMXF
Nymox Pharmaceutical Corp
14 Aug 20
Prospectus supplement for primary offering
6:02am
424B5
NYMXF
Nymox Pharmaceutical Corp
14 Aug 20
Prospectus supplement for primary offering
12:00am
6-K
NYMXF
Nymox Pharmaceutical Corp
13 Aug 20
Current report (foreign)
12:00am
6-K
NYMXF
Nymox Pharmaceutical Corp
12 Aug 20
Nymox Announces $9 Million Registered Direct Offering
8:58am
6-K
NYMXF
Nymox Pharmaceutical Corp
20 Jul 20
Current report (foreign)
4:21pm
424B5
NYMXF
Nymox Pharmaceutical Corp
17 Jul 20
Prospectus supplement for primary offering
4:37pm
6-K
NYMXF
Nymox Pharmaceutical Corp
14 May 20
Current report (foreign)
4:40pm
EFFECT
NYMXF
Nymox Pharmaceutical Corp
13 May 20
Notice of effectiveness
12:15am
CORRESP
NYMXF
Nymox Pharmaceutical Corp
7 May 20
Correspondence with SEC
12:00am
F-3/A
NYMXF
Nymox Pharmaceutical Corp
6 May 20
Shelf registration (foreign) (amended)
12:00am
F-3/A
NYMXF
Nymox Pharmaceutical Corp
24 Apr 20
Shelf registration (foreign) (amended)
5:15pm
6-K
NYMXF
Nymox Pharmaceutical Corp
24 Apr 20
Current report (foreign)
12:00am
UPLOAD
NYMXF
Nymox Pharmaceutical Corp
10 Apr 20
Letter from SEC
12:00am
F-3
NYMXF
Nymox Pharmaceutical Corp
3 Apr 20
Shelf registration (foreign)
1:50pm
20-F
2019 FY
NYMXF
Nymox Pharmaceutical Corp
Annual report (foreign)
30 Mar 20
3:36pm
6-K
NYMXF
Nymox Pharmaceutical Corp
19 Nov 19
Notice of the Annual General Meeting of the Shareholders
2:55pm
6-K
NYMXF
Nymox Pharmaceutical Corp
13 Nov 19
Current report (foreign)
3:36pm
6-K
NYMXF
Nymox Pharmaceutical Corp
14 Aug 19
Current report (foreign)
3:41pm